Supplementary Materials for the MR analysis between DM and malignant skin tumors

Table S1 Characteristics of instrumental variables for T1DMTable S2 Characteristics of instrumental variables for T2DMTable S2 Characteristics of instrumental variables for T2DMTable S4 SNPs from GWAS on T1DM and MMTable S5 SNPs from GWAS on T1DM and NMSCTable S6 SNPs from GWAS on T1DM and BCCTable S7 SNPs from GWAS on T2DM and MMTable S8 SNPs from GWAS on T2DM and NMSCTable S9 SNPs from GWAS on T2DM and BCCTable S10 SNPs from GWAS on GD and MMTable S11 SNPs from GWAS on GD and NMSCTable S12 SNPs from GWAS on GD and BCCTable S13 Heterogeneity of MR analysis for diabetes and malignant skin tumorsTable S14 The results of MR-Egger intercept analysis, MR-Pleiotropy residual sum and outlier methods for risk of diabetes and malignant skin tumorsAbbre.: T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus; GD, gestational diabetes; MM, melanoma; NMSC, non-melanoma skin cancer; BCC, basal cell carcinoma; MR, Mendelian randomization; EA, effect allele; OA, other allele; SE, standard error; SNP, single nucleotide polymorphisms;